Summary. Glucose-induced insulin secretion is lost in the face of chronic hyperglycaemia. The same defect is present when normal rats are made hyperglycaemic by 48-h glucose infusions. Insulin secretory responses were mapped out during the post-infusion period in order to determine how long it takes for normal Beta-cell function to recover, and to identify factors which influence the rate of recovery. Male Sprague Dawley rats weighing 200-250 g were infused with 50% glucose or 77 mmol/1 NaC1 for 48 h. The glucose-infused rats were mildly hypoglycaemic for 14 h after the infusion ceased. Glucose-induced insulin secretion, absent at the end of the glucose infusion, was normal 6 h post-infusion. Such rapid recovery was not because of the short duration of hyperglycaemia; mild hypoglycaemia from a 5-h insulin infusion in 90% pancreatectomized rats resulted in a four-fold rise in glucose-induced insulin secretion. Under in vitro conditions, extreme glucose deprivation caused by perfusing the pancreas of glucose-infused rats with buffer devoid of glucose restored glucose-induced insulin secretion in just 37 min. Therefore, the suppression of glucose-induced insulin release by chronic hyperglycaemia is a dynamic situation that requires ongoing hyperglycaemia to prevent the reappearance of glucose responsiveness. This study shows recovery of glucose-induced insulin secretion after just 6 h of mild hypoglycaemia in vivo and even faster recovery with more severe glucose deprivation in vitro. Our results suggest that there is an inverse relationship between the rate of return of Betacell glucose responsiveness and the ambient glucose concentration.
Normally, the plasma glucose concentration exerts the dominant influence over insulin secretion. Type 2 (noninsulin-dependent) diabetes mellitus is characterized by Beta cells which no longer respond to a changing glucose level [1] [2] [3] [4] . We have proposed that glucose-induced insulin secretion is lost as a direct result of Beta cells being exposed to a chronically elevated glucose concentration [4, 5] . Support for this idea has come from animal studies in which normal rats made hyperglycaemic through a variety of mechanisms develop a similar defect [6.9] , and also that normalizing the plasma glucose concentration in these rats with phloridzin restores glucose-induced insulin secretion [10, 11] .
Little is known about reversal of secretory defects in non-insulin-dependent diabetes mellitus except that restoration of euglycaemia often results in the reappearance of glucose-induced insulin release [4, [12] [13] [14] . The recovery time has not been mapped out, nor has much been learned about what conditions speed up or retard recovery. Animal models should theoretically provide a way to investigate this question, but reversal studies in hyperglycaemic rat models have provided conflicting results. Using in vitro techniques, glucose-induced insulin secretion has been restored in as little as 40 min [15] . In contrast, in vivo insulin injections have proved to be of varying success and require days to work [16] [17] [18] . Part of the discrepancy in these results could reflect the difficulty in attaining precise metabolic control in rats using standard treatments. Alternatively, there may be variables which influence insulin secretion in vivo and are negated by the in vitro techniques.
We have reported that normal rats made hyperglycaemic with 48-h glucose infusions develop Beta-cell glucose unresponsiveness [8, 19] . With this technique, one has a unique opportunity to study reversal of the secretory defects by simply turning off the infusion. This approach was used in this study to map out recovery of Beta-cell glucose responsiveness.
Materials and methods
cose potentiation of arginine-induced insulin release at 0, 6, 14, and 24 h.
Chronic glucose infusion rat model
The glucose infusion method has been described previously [8] . During sodium amobarbital anaesthesia (100 mg/kg i. p.), jugular venous catheters were placed into male Sprague Dawley rats weighing 200-250 g (Charles River, Wilmington, Mass., USA). The next day, infusions were started using a Sage syringe pump (Model 355, Orion, Cambridge, Mass., USA) and an infusion device consisting of a swivet with a hollow metal cable running from it to a neck ring and Velcro vest (Emdie, Goochland, Va., USA). The standard protocol was 50% glucose (weight/volume) or the diluent 77 mmol/1NaC1 infused at 2 ml/h for 48 h. Studies were carried out at selected time points after turning off the pump (termination point labelled time 0).
90% pancreatectomy rat model (Px)
Protocol 3: Beta-cell glucose responsiveness in Px rats post-insulin infusion. At 4 to 6 weeks post 90% Px rats underwent venous catheterization. The next day, 1 ml/h infusions were carried out followed by in vitro pancreas perfusion. Infusion protocols: 0.12 IU/h Actrapid insulin (Squibb-Novo, Princeton, NJ, USA) for 5 h, the pancreas was perfused 1 h later, or 154 mmolll NaCI + 0.25% bovine serum albumin (diluent) for 6 h. Blood samples (30 gl) were obtained hourly for plasma glucose values.
Analytical methods
Plasma glucose was measured with a Beckman Glucose Analyzer II (Beckman, Brea, Calif., USA). Insulin concentrations were determined by an RIA which used charcoal separation [21] and rat insulin standards (Eli Lilly, Indianapolis, Ind., USA).
90% pancreatectomies were performed on 5-week-old male Sprague Dawley rats using the method of Bonner-Weir et al. [7] . During sodium amobarbital and ether anaesthesia, a midline abdominal incision was made and the pancreas was mobilized by gently breaking mesenteric connections with the stomach, bowel and retroperitoneum. Cotton applicators were used to abrade pancreatic tissue away from the major blood vessels leaving only the portion bordered by the bile duct and the duodenum. Post-operatively, rats were given standard rat chow and tap water ab libitum for 4 to 6 weeks.
In vitro peffused pancreas
This technique has been described in detail [20] . Prior to anaesthetizing with sodium amobarbital, rats were weighed and blood samples (0.5 ml) were collected by tail snipping for insulin and glucose measurements. Perfusate: Krebs-Ringer bicarbonate buffer pH 7.4 plus 4% dextran T70 (Sigma, St. Louis, Mich., USA), 0 or 2.8 mmol/1 glucose, 2 mmol/1 Ca 2+, 1.2 mmol/1Mg 2+, and 0.2% bovine serum albumin fraction V (Sigma). After being bubbled for 20 rain with 95% 02/5% CO2, the perfusate was stored at 38~ in a temperature controlled reservoir; where appropriate, perfusate containing 10 mmol/1 arginine was stored in a second reservoir. Higher glucose concentrations were achieved with a sidearm syringe which added 0.2 ml to the usual flow rate of 3 ml/min. Following cannulation of the aorta and portal vein, the body cavity was covered with gauze soaked in saline and maintained at 36-39~ by a heat lamp. The initial 20 min served as an equilibration period during which no samples were taken. Thereafter, samples were collected in chilled tubes containing 4 mg EDTA and kept on ice pending storage at -20~
The pancreas was excised at the end of each perfusion, blotted, weighed, and stored in acid ethanol at -20~ Later, on a single day, they were homogenized with an Ultra Turrex (Tekmar, Cincinnati, Ohio, USA), diluted to a volume of 8 ml acid ethanol, and refrozen pending assay for insulin content.
Protocol 1: Glucose-induced insulin secretion after in vitro glucopoenia in glucose-infused rats. Rats were infused with 50% glucose or 77 mmol/1 NaCt for 48 h. Glucose-induced insulin secretion was assessed after in vitro perfusion of the pancreas for 37 rain with 0 or 5.5 mmol/l glucose.
Protocol2: Beta-cell glucose responsiveness post-glucose infusion.
Rats were infused with 50% glucose or 77 mmoI/1 NaC1 for 48 h. Post-infusion insulin responses were mapped out in vitro using the perfused pancreas technique. Glucose-induced insulin release was assessed at 0 (termination point of the infusion), 4, and 6 h, and glu-
Data presentation and statistical analysis
All data are expressed as mean _+ SEM. Protocols for the perfused pancreas studies are shown at the top of each figure. The incremental insulin responses listed in the tables represent the total amount of insulin released for that secretagogue above the baseline secretory rate; they were calculated by subtracting the last sample taken during the preceding perfusate from the mean insulin concentration during the test perfusate, then multiplying by flow rate and duration. Analysis of variance (ANOVA) was used to determine statistical significance. (Table 1) Plasma glucose and insulin values were obtained up to 24 h after stopping the NaC1 and glucose infusions. As expected, neither value changed in the NaC1 group. Glucose-infused rats were markedly hyperglycaemic and (6) The values in the parentheses are the number of animals in each group.
Results

Plasma glucose and insulin values post-infusion
(a) no samples were taken in NaCl-infused rats 14-h post-infusion. Statistical significance was determined using one-way analysis of variance (ANOVA). Each value in the glucose-infused rats was compared to the corresponding value in the NaC1 group. ap<0.001, bp<0.05 Pancreases were obtained after in vitro perfusion. The values in parentheses are the number of animals in each group. Statistical significance was determined using one-way analysis of variance (ANOVA). Each glucose-infused group was compared to the corresponding value in the rats infused with NaC1. p<0.001, b p<0.05 cose for 37 rain, and then a re-challenge with 16.7 mmol/1 glucose.
The results in the NaCl-infused groups were essentially the same; the insulin responses to the high glucose challenge were very similar whether the preceding perfusate contained 0 or 5.5 mmol/1 glucose. In the glucose-infused rats, both low glucose perfusates paradoxically raised the insulin concentration. Continued delivery of 5.5 mmol/1 glucose caused insulin output to return to the baseline level followed by an incremental insulin response to the high glucose challenge which was less than that of the control groups. In contrast, the glucose-free perfusate reduced insulin output to the negligible levels seen in the controls, and the insulin response to high glucose was five times that of the previous group, even surpassing that of the control group.
hyperinsulinaemic. After stopping the infusion, plasma glucose fell precipitously to a level below that of the control rats. Even 24 h post-infusion, there was a tendency for the glucose value to be reduced (6.4 + 0.4 mmol/1 glucose-infused vs 7.5 + 0.3 mmol/1 NaCl-infused, p < 0.07). In spite of the hypoglycaemia, plasma insulin declined slowly taking 14 h to fall below the level of the control animals. (Table 2) Insulin content was reduced by 75% at the end of the glucose infusion. It took 14 h for the content to return to normal. (Fig.i) . Rats were studied directly after a 48-h infusion of 50% glucose or 77retool/1 NaC1. The baseline perfusate contained 16.7 mmol/1 glucose followed either by 0 or 5.5 mmol/1 gluProtocol 2: Beta-cell glucose responsiveness post-glucose infusion. Insulin secretion post-infusion was mapped out with the in vitro perfused pancreas. Glucose-induced insulin release was assessed with the following protocol: 16.7 mmol/1 glucose followed in turn by 2.8 mmol/1 for 10 min and 16.7 mmol/1 for 15 rain (Fig. 2) . Pancreas from the NaCl-infused controls behaved as expected with suppression of insulin output during low glucose followed by a large biphasic response to high glucose. The results at the end of the glucose infusion were entirely different; insulin release paradoxically increased during exposure to the low glucose concentration while changing to high glucose had virtually no effect on insulin output. Four h later, the pattern of insulin output was more normal looking, with the paradoxical rise to low glucose having almost disappeared and high glucose now causing a definite biphasic response. However, the size of that response was only a fourth of the control value (Table 3 ). Six h after stopping the infusion, suppression and stimulation of insulin release were both essentially normal.
Pancreatic insulin content post-infusion
Protocol 1: Glucose-induced insulin secretion after in vitro glucopoenia in glucose-infused rats
Next, glucose potentiation of arginine-induced insulin secretion was assessed by giving 5-rain infusions of (rain) 643 Fig. 2 A-D . Glucose-induced insulin secretion in normal rats following a 48-h infusion of 50% glucose or 77 mmol/l NaCI. Insulin secretion was assessed in vitro with the perfused pancreas technique. Peffusion protocol: 16.7 mmol/1 glucose followed in turn by 2.8 mmol/l for 10 rain and 16.7 retool/1 for 15 min. Glucoseinfused rats were studied at the end of the infusion (B), 4 (C) or 6 h (D) later. NaCl-infused rats were studied at the end of the infusion (A), Each group consisted of five or six animals Table 3 . Glucose-induced insulin secretion in normal rats after a 48-h infusion of 50% glucose or 77 mmol/1 NaC1 assessed with the in vitro perfused pancreas The values in parentheses are the number of animals in each group. The value at 2.8 mmol/1 glucose is the amount of insulin released during the last min of that perfusate. Statistical significance was determined using one-way analysis of variance (ANOVA). Each glucose-infused group was compared to the corresponding value in the rats infused with NaCl. b p<0.001, Cp<0.05 10 mmol/1 arginine at 2.8 and 16.7 mmol/1 glucose (Fig. 3) . Glucose potentiation was clearly evident in the NaCl-infused rats; the arginine response at low glucose was trivial compared to that at high glucose concentration. In contrast, at the end of the glucose infusion, the glucose concentration had no effect on arginine-induced insulin release; both insulin responses were large (exceeding that of the control animals at 16.7 mmol/1 glucose) and nearly identical. Contrary to the previous protocol in which glucose-induced insulin release normalized within 6 h of turning off the infusion, the arginine response at low glucose was still well above normal (Table 4 ) so that the study was extended to 14 and then 24 h post-infusion. At 14 h, the response to arginine at low glucose was still 10 times that of the control animals. Unexpectedly, at 24 h the arginine responses at both glucose concentrations were higher than at 14 h and were clearly above those of the control rats.
Protocol3: Beta-cell glucose responsiveness in Px rats post-insulin infusion. Glucose-induced insulin secretion
was normal 6 h after stopping the glucose infusion. However, this model is characterized by a short duration (48 h) of hyperglycaemia, and it was not clear if as rapid return of glucose responsiveness would be possible had the duration of hyperglycaemia been longer. To answer this question, 90% Px rats were infused with insulin to mimic the experimental conditions that followed termination of the glucose infusion. Px rats develop a 1-2 mmol/l rise in plasma glucose within a week of the surgery [7] ; they were studied 4-6 weeks after the Px surgery so that the duration of hyperglycaemia was at least 3 weeks.
In the insulin-infused Px rats, plasma glucose fell within 2 h, from 8.5 _+ 0:4 mmol/1 to 3.9_+0.1 mmol/1 (Fig.4) . The perfusion surgery was started 1 h after stopping the infusion at a time when the glucose value had returned to 8.7 _+ 0.7 mmol/1. Perfusion protocol: 7.8 mmol/1 glucose followed in turn by 2.Smmol/1 glucose xl0min, 16.7 mmol/l glucose x 15 min, and 16,7 mmol/1 glucose + 10 mmol/1 arginine x 8 min (Fig.5) . The NaCl-infused Px rats showed the typical pattern of selective glucose unresponsiveness with high glucose causing a meager later. NaCl-infused rats were studied 24 h post-infusion (A). Each group consisted of four or five animals Table 4 . Glucose influence over arginine-induced insulin secretion in normal rats after a 48-h infusion of 50% glucose or 77 mmol/1 NaC1 assessed with the in vitro perfused pancreas The values in parentheses are the number of animals in each group. Statistical significance was determined using one-way analysis of variance (ANOVA). Each glucose-infused group was compared to the corresponding value in the rats infused with NaC1. ap<0.001, b p<0.05 in rats 4-6 weeks after a 90% pancreatectomy. The sample at 6 h in the insulin-infused rats was collected 1 h post-infusion insulin response as compared to arginine (note the scale change on Fig.5 ). After the insulin infusion, the insulin response to 16.7mmol/1 glucose increased four-fold (17.6 +_ 3.53 pmol/15 min Px-insulin vs 4.75 + 1.00 pmol/15 rain Px-NaC1, p < 0.02) and that to arginine doubled (82.7 + 14.5 pmol/8 rain Px-insulin vs 44.7 + 4.36 pmol/8 rain Px-NaC1, p < 0.06). These improvements were not accompanied by any change in pancreatic insulin content (3.6 + 0.6 nmol/pancreas Px-insulin vs 4,0 + 0.5 nmol/pancreas Px-NaC1).
Discussion
The glucose-infused rats were characterized by near total loss of glucose influence over insulin secretion; direct stimulation of insulin secretion and glucose modulation of arginine-hlduced insulin output (referred to as glucose potentiation) were both absent. Perfusing the pancreas of these rats in vitro for just 37 rain with glucose-flee buffer restored glucose-induced insulin secretion such that the insulin response to a glucose challenge now exceeded that of the NaCl-infused control rats. In contrast, perfusate containing 5.5 mmol/1 glucose (well below the normal plasma glucose value in rats) failed to achieve the same effect, indicating that the return of glucose-induced insulin secretion was not simply an effect of removing hyperglycaemia but instead depended on the absence (or possibly extremely low level) of glucose. The same observation has been made in other hyperglycaemic rodent models [15, 22, 23] suggesting that rapid restoration of glucose responsiveness in the presence of profound glucopoenia is a fundamental characteristic of hyperglycaemia-associated Beta-cell dysfunction. Some aspects of these findings need to be emphasized. First, glucose-induced insulin secretion normalized in just 37 min which is important from a mechanistic point of view, for it tells us that the biochemical changes in the Beta-cell that lead to recovery of glucose-induced insulin secretion are not dependent on protein synthesis. A current hypothesis is that glucose-induced insulin secretion is lost secondary to a reduced level of the high Km Beta-cell glucose transporter [24] . This possibility is not easily reconciled with the rapid reversibility of the secretory defect as shown in this study. More consistent with our findings is the hypothesis that excess accumulation of glycogen within the Beta-cell is responsible for the secretory defects [25, 26] . It was demonstrated more than 20 years ago that the glycogen stores in Beta cells of hyperglycaemic rats are mobilized within 45 min of being exposed in vitro to a very low glucose concentration [27] . Second, the rapid reversability may explain the paradox whereby perfused pancreas studies in diabetic rat models have routinely shown loss of glucose-induced insulin output [28] whereas isolated islets from these same rats are normally glucose responsive [29] [30] [31] . The most likely explanation is that during the several hour isolation procedure Beta cells are no longer exposed to the same high glucose levels which occur in vivo, thereby allowing glucose-induced insulin secretion to revert to normal. Support for this idea has come from recent studies which have shown partial preservation of secretory defects in islets from glucose-infused normal rats when the solutions used in the isolation procedure contain higher than normal glucose concentrations [32, 33] .
It has been considerably more difficult to study reversal of insulin secretory defects under in vivo conditions, in part because of problems in attaining precise metabolic control in rats using insulin injections. We took the approach of mapping out insulin secretion patterns in glucose-infused normal rats during the post-infusion period. Glucose-induced insulin secretion was normal 6 h after turning off the infusion. The glucose infusion method entails relatively short-term hyperglycaemia, and it was not clear if the reversal would have been as fast if the exposure to hyperglycaemia had been longer. This question was answered by showing that a 6-h insulin infusion caused a four-times higher insulin response to an in vitro glucose challenge in the Px model which is characterized by several weeks of hyperglycaemia. Thus, even after a protracted period of hyperglycaemia, mild hypoglycaemia allows Beta-cell glucose responsiveness to reappear within a few hours. These results contradict a previous study which suggested that recovery of glucoseinduced insulin secretion in vivo requires several days of insulin treatment [18] . On the other hand, we cannot exclude the possibility that a counter-regulatory rise in glucagon release accelerated the return of glucose-induced insulin secretion.
In contrast to glucose-induced insulin secretion normalizing within 6 h of stopping the glucose infusion, glucose influence over arginine-induced insulin release was still abnormal 24 h post-infusion. This latter result was somewhat surprising since 24 h of insulin therapy fully reverses the same defect in neonatal streptozotocin rats [16, 18] ; the longer duration in this study may reflect the greater degree of hyperglycaemia in the glucose-infused model. Regardless of this, the striking finding is the dis-parity in the timing of recovery of glucose-induced insulin secretion vs glucose potentiation. The time which it takes for these two defects to develop in glucose-infused rats is also quite different [19] . The most plausible explanation for these observations is that the loss of glucose-induced insulin secretion and the loss of glucose potentiation result from separate molecular abnormalities.
Our results clearly show that suppression of glucose-induced insulin release by chronic hyperglycaemia is a dynamic situation that requires ongoing hyperglycaemia to prevent reappearance of glucose responsiveness. The in vitro results showed that a very low glucose concentration accelerates the recovery of normal Beta-cell function. However, it should not be inferred that the same principle applies in vivo. Any benefits of marked hypoglycaemia to promote a return of glucose responsiveness would have to compete with associated factors which inhibit insulin secretion such as hyperinsulinaemia [34] and increases in circulating catecholamines [35, 36] . Hypoglycaemia-induced suppression of insulin secretion presumably explains our unexpected finding that arginine-induced insulin release at 16.7 mmol/1 glucose fell after turning off the glucose infusion but then rose again 24 h later.
In summary, the in vitro approach allows study of hyperglycaemia-induced Beta-cell dysfunction in an environment in which the ambient glucose level is the only factor known to influence the rate of recovery of Beta-cell glucose responsiveness. These results suggest that the lower the glucose level, the faster is recovery. In contrast, the in vivo state is much more complex with additional factors related to hypoglycaemia being able to suppress insulin secretion and thereby counter-balance any beneficial effects. These results have important implications for the therapy of Type 2 diabetes for which a desireable therapeutic endpoint is to optimize endogenous Beta-cell function. To attain this goal, treatment strategies must successfully maintain the delicate balance between sufficient lowering of glucose values to negate any effects of hyperglycaemia while avoiding hypoglycaemia. Unfortunately, the current approaches for close metabolic control using insulin are frequently accompanied by hypoglycaemia [37] which might argue for the development of new innovative management programmes based on the aggressive use of diet, weight reduction, and oral agents.
